A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis

Completed · Phase 4

Conditions studied: Bacterial Conjunctivitis

In brief

This is a 7 day study to evaluate the safety and efficacy of topical gatifloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in subjects from birth to 31 days of age

Key facts

Study ID

NCT00464438

Run by

Allergan

People needed

171

Starts

2007-06-01

Expected to finish

2008-09-01

Last updated by the study team

2011-09-21

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diagnosed with bacterial conjunctivitis

You may not qualify if…

• chemical or foreign body trauma to either eye
• infection in either eye (besides bacterial conjunctivitis)
• white spots in the cornea or ulcers in either eye
• clinical diagnosis of chlamydia or gonorrhea in either eye

Where it is running

• Study site — Sacramento, California, United States
• Study site — Whitby, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.